| 80.17 -1.42 (-1.74%) | 10-23 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 98.38 | 1-year : | 114.9 |
| Resists | First : | 84.23 | Second : | 98.38 |
| Pivot price | 78.64  |
|||
| Supports | First : | 75.91 | Second : | 70.76 |
| MAs | MA(5) : | 80.66 |
MA(20) : | 77.65 |
| MA(100) : | 103.19 |
MA(250) : | 146.38 |
|
| MACD | MACD : | -0.6 |
Signal : | -1.6 |
| %K %D | K(14,3) : | 76.6 |
D(3) : | 80.7 |
| RSI | RSI(14): 49.9 |
|||
| 52-week | High : | 216 | Low : | 70.76 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ INSP ] has closed below upper band by 31.7%. Bollinger Bands are 63.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 84.28 - 84.71 | 84.71 - 85.04 |
| Low: | 80.52 - 80.97 | 80.97 - 81.31 |
| Close: | 80.89 - 81.63 | 81.63 - 82.2 |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Wed, 22 Oct 2025
3 Reasons INSP Has Explosive Upside Potential - TradingView
Tue, 21 Oct 2025
Inspire Medical Systems (INSP) Shows Improved Sleep Apnea Outcomes with Inspire V System - Insider Monkey
Tue, 21 Oct 2025
How Investors Are Reacting To Inspire Medical Systems (INSP) Strong Inspire V Trial Results and Operational Gains - simplywall.st
Mon, 20 Oct 2025
Inspire Medical Systems, Inc. (INSP) Stock Analysis: 60% Potential Upside Amidst Healthcare Innovations - DirectorsTalk Interviews
Sun, 19 Oct 2025
Inspire Medical Systems (INSP): Assessing Valuation After New Inspire V Clinical Results and Improved Patient Outcomes - Sahm
Wed, 15 Oct 2025
Truist Securities Maintains Inspire Medical Systems (INSP) Hold Recommendation - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 30 (M) |
| Shares Float | 27 (M) |
| Held by Insiders | 1.1 (%) |
| Held by Institutions | 121 (%) |
| Shares Short | 2,650 (K) |
| Shares Short P.Month | 2,350 (K) |
| EPS | 1.74 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 22.92 |
| Profit Margin | 6.1 % |
| Operating Margin | -1.6 % |
| Return on Assets (ttm) | 3.3 % |
| Return on Equity (ttm) | 8 % |
| Qtrly Rev. Growth | 10.8 % |
| Gross Profit (p.s.) | 24.6 |
| Sales Per Share | 29.12 |
| EBITDA (p.s.) | 1.76 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 117 (M) |
| Levered Free Cash Flow | 55 (M) |
| PE Ratio | 46.05 |
| PEG Ratio | 0 |
| Price to Book value | 3.49 |
| Price to Sales | 2.75 |
| Price to Cash Flow | 20.17 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|